Dublin, July 24, 2017 -- The "Global Topical Drug Delivery Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.
Global Topical Drug Delivery Market is Expected to Reach USD 194.2 Billion by 2024, at a CAGR 9.3% During the Forecast Period of 2017 to 2024
Topical drug delivery involves the introduction of a medication to the body surface such as skin or mucous membrane or to the circulatory system by periodic transdermal drug delivery for the treatment of diseases. It is considered as key route for local and systemic treatment. Drugs delivered through this route of administration penetrate deeply into the skin and are better absorbed. Topical drugs such as sunscreens and astringents are used for prophylaxis.
They are used in the treatment of skin conditions such as bacterial, fungal, and viral infections; inflammation; pruritus; corns; warts; and other dermatologic conditions. Also products such as transdermal patches provide systemic drug delivery non-invasively. Topical drug delivery includes liquid, semi-solid, solid, and transdermal patches and gels.
Key Topics Covered:
1 Introduction
1.1. Overview of the Global Topical Drug Delivery Market
1.2. Market Segmentation & Coverage
1.2.1. Currency and Pricing
1.2.2. Limitation
1.2.3. Stakeholders
2 Research Methodology
2.1. Key Takeaways
2.2. Arriving at the Global Topical Drug Delivery Market Size
2.2.1. Market Crackdown Approach
2.2.2. Company Revenue and Market Share Analysis
2.2.3. Data Triangulation
2.2.4. Key Data Points from Primary Sources
2.2.5. Product Pipeline Analysis
2.2.6. Porter's Five Forces Matrix
2.4. Global Topical Drug Delivery Market: Research Snapshot
2.5. Assumptions
3 Market Landscape Summary
4 Premium Insights
4.1. Overview
4.2. Global Topical Drug Delivery Market: Key Primary Insights
4.3. Market Overview
4.3.1. Drivers
4.3.1.1. Rising Prevalence of Chronic Disease Such as Diabetes
4.3.1.2. Growth in Transdermal Technology
4.3.1.3. Innovation and Development of New Drug Types
4.3.1.4. Better Healthcare Spending in South Asia and Africa
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Threats
4.4. Key Market Trends and Upcoming Technologies
5 Executive Summary
6 Topical Drug Delivery Market, by Product Type
6.1. Overview
6.2. Topical Drug Delivery, by Product Type
6.2.1. Transdermal Drug Delivery Devices, by Product Type
6.2.1.1. Transdermal Patches
6.2.1.2. Transdermal Gels
6.2.2. Topical Drug Delivery Formulations, by Form
6.2.2.1. Liquid Topical Drug Delivery Formulations, by Type
6.2.2.1.1. Solutions
6.2.2.1.2. Suspensions
6.2.2.2. Semi-Solid Topical Drug Delivery Formulations, by Type
6.2.2.2.1. Gels
6.2.2.2.2. Creams
6.2.2.2.3. Ointments
6.2.2.2.4. Pastes
6.2.2.2.5. Lotions
6.2.2.3. Solid Topical Drug Delivery Formulations, by Type
6.2.2.3.1. Suppositories
6.2.2.3.2. Powders
7 Topical Drug Delivery Market, by End-User
7.1. Overview
7.2. Hospitals
7.3. Home Healthcare
7.4. Clinics
7.5. Diagnostic Centers
7.6. Others
8 Topical Drug Delivery Market, by Distribution Channel
8.1. Overview
8.2. Hospital Pharmacies
8.3. Pharmacy Stores
8.4. Direct Tenders
8.5. Online Pharmacy
9 Topical Drug Delivery Market, by Geography
10 Topical Drug Delivery Market: Competitive Landscape
11 Topical Drug Delivery Market, Company Profiles
- 3M Drug Delivery Systems
- Antares Pharma Inc.
- Biofarmitalia S.R.L
- Crescita Therapeutics
- Easton Pharmaceuticals Inc.
- Endo Pharmaceuticals Inc.
- Galderma S.A.
- Hisamitsu Pharmaceutical Co. Inc.
- Janssen Pharmaceuticals Inc. (A J&J Company)
- Lohmann Therapie-Systeme AG
- Mylan Pharmaceuticals Inc.
- Nitto Denko Corporation
- Pharmatek Laboratories Inc.
- Prosollus Pharmaceuticals
- Samyang Biopharmaceuticals Corporation
- Sheffield Pharmaceuticals Inc.
- Solvay
- Stiefel Laboratories Inc.
- Tapemark
- Therasolve NV
- Transdermal Technologies Inc.
- Valeant Pharmaceuticals International Inc.
For more information about this report visit https://www.researchandmarkets.com/research/f3cx57/global_topical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



